carboxytolbutamide has been researched along with midazolam in 1 studies
Studies (carboxytolbutamide) | Trials (carboxytolbutamide) | Recent Studies (post-2010) (carboxytolbutamide) | Studies (midazolam) | Trials (midazolam) | Recent Studies (post-2010) (midazolam) |
---|---|---|---|---|---|
23 | 2 | 0 | 9,834 | 3,191 | 3,301 |
Protein | Taxonomy | carboxytolbutamide (IC50) | midazolam (IC50) |
---|---|---|---|
Cytochrome P450 3A4 | Homo sapiens (human) | 2.7427 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, H; Li, Q; Liu, C; Song, N; Zhang, S | 1 |
1 other study(ies) available for carboxytolbutamide and midazolam
Article | Year |
---|---|
Liquid chromatography/tandem mass spectrometry method for simultaneous evaluation of activities of five cytochrome P450s using a five-drug cocktail and application to cytochrome P450 phenotyping studies in rats.
Topics: Animals; Chromatography, Liquid; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Cytochromes; Male; Mephenytoin; Midazolam; Phenacetin; Phenotype; Rats; Rats, Wistar; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry; Tolbutamide | 2008 |